 |
   
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
TAGline
|
Email
Print-Friendly
Glossary| The Panel Speaks |
|
In a letter dated 10/04/04, the PHS guidelines panel notified Dr. Paul Bellman of its decision regarding the "ban" on hydroxyurea: "Since hydroxyurea is not approved for [the treatment of HIV], we have decided to remove it from the new guidelines revision ... anticipated to be available ... at the end of October." -- Alice K. Pau, Pharm.D., Executive Secretary, Panel on Clinical Practices for the Treatment of HIV Infection, Public Health System, Department of Health and Human Services |
This article was provided by Treatment Action Group. It is a part of the publication TAGline.
 | ||
|
|
 |
 |
The Body: About The Body | Contact The Body | Site Policies | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
